Barbara A. Goff

TL;DR: GC plus BV followed by BV until progression resulted in a statistically significant improvement in PFS compared with GC plus PL in platinum-sensitive ROC, and the primary end point was progression-free survival by RECIST.

TL;DR: For example, this article found that women who ignored their symptoms were significantly more likely to be diagnosed with advanced disease compared with those who did not (P = 0.002) and the time required for a health care provider to make the diagnosis was reported as less than 3 months by 55%, but greater than 6 months by 26% and greater than 1 year by 11%.

TL;DR: Compared with clinic controls, symptoms that are more severe or frequent than expected and of recent onset warrant further diagnostic investigation because they are more likely to be associated with both benign and malignant ovarian masses.

TL;DR: The need for complete surgical staging in all patients with UPSC regardless of depth of invasion is reinforced, as grade and depth of myometrial invasion were not significant predictors for extrauterine disease.

TL;DR: Currently, screening for ovarian cancer is not recommended for the general population, but targeting women with specific symptoms for screening has been evaluated only recently, because it was believed that symptoms had limited specificity.